Skip to main content
No. of Recommendations: 29
Hi,
I'm new to the board but I appreciate the no-nonsense analysis of business metrics I see here for prospective investments. So I was hoping to elicit some feedback on what appears to me a promising business to invest in called Doximity (DOCS).

I work in healthcare and doximity is a HIPAA compliant tool that my colleagues and I primarily use to do telehealth--either by phone or by video. It is billed as a "social media company" for doctors and other healthcare workers (I guess it is that as well, though this is not how I or those I know use it.) As a product it is excellent, and is the most glitch-free and slick of the telehealth platforms we are authorized to use (we do not use zoom, so I can't compare). The other options we are authorized to use often have problems--the patient's computer isn't set up right, the internet is too slow to support quality video, or the alternative software is glitching again. Doximity is much easier to use for patients generally and more reliable. It has this cool electronic fax feature so that you can fax things without having a real fax machine. It reportedly has an esignature utility that could be really useful. When I first discovered it I was telling everyone I knew at work about it because it makes our professional lives much easier.

So that's my anecdotal impressions of the product itself. The numbers from a business standpoint are also excellent.

From fiscal 2022 first quarter results (aug 10):

--167 percent net revenue retention for the trailing 12 months
--Revenue increased 100% yoy from 36.4 to 72.7 million
--GAAP income of 26.3 million versos 1.5 million June 2020
--gaap margin of 36% and Non gaap margin of 42%
--adjusted EBITDA of 31.2 million vs 3.9 million in June 2020
--operating cash flow of 33.2 million vs 8.8 million in June 2020
--cash position of 726.5 million (after raising 548 million from IPO on June 28 2021).
--guiding for revenue of 296.5 million to 2099.5 million for fiscal year ending march 31, 2022.



Pros:

-has the market cornered already--is this a kind of de facto "moat?" people speak of--with 80 percent of all doctors using it.
-excellent product
-revenue retention is excellent



Concerns:

-80 percent of doctors already use it, so is there sufficient room to grow? (possible answer to this is that there are many other health care professionals--social workers, nurses, CNAs, etc., who don't use it who could become users down the line).
-i'm unclear on how much money the company makes from subscriptions vs ads, and I wonder how fast the ad revenue can grow with subscriptions among doctors already nearly hitting its cap.


This is my first post and my first real attempt to find a high growth company that has continued room to run. Sorry if I am not highlighting the most relevant info here. I'm interested in feedback about this company as a possible investment. Thanks.
Print the post Back To Top
No. of Recommendations: 5
A couple of things I recommend:
1. In general, use the search page linked at right (the one for Saul's board posts) when considering intro-ing a new stock, and
2. specifically, check out these two threads that mention Doximity specifically (found via said search page):

From 6/29/21, an official bringing-DOCS-to-the-board thread:
https://boards.fool.com/doximity-docs-new-company-34863509.a...
and from 5/31/21, some mentions in a thread on TDOC:
https://boards.fool.com/physicians-implementing-telehealth-3...

Hopefully both of these steps will help any newer folks going forward. : )

-n8 (I have no position in DOCS but sold TDOC earlier this summer)(also welcome to Saul's!)
And recommendation zero, of course, is to be highly familiar with the Knowledge Base when posting.
Print the post Back To Top
No. of Recommendations: 1
Revenue is certainly not accelerating.

The last 2 quarters, the increase has been decreasing from the Q before.
Print the post Back To Top
No. of Recommendations: 1
I also took DOCS on my watch list for a while but couldn’t pull the trigger.
As my point of view, TDOC had already run to their limit to reach the hospital industry. But DOCS seems like more suitable for real doctors. It sponsored by drug companies which sales already like hard working bees around the hospital and bothering doctors to selling their drugs. So I believe this will be good way for sales to reach out doctors.
And also this social media need verify your identity so inside community people will feel more comfortable. The biggest moats and risk is they already have 80% shares so how do they move on to the other regions or nations is very uncertainty.

Sorry, still no clue for this one.

Best
Print the post Back To Top